Financial News
Latest News about ROIV
Recent news which mentions ROIV
Immunovant Ditches Seeking FDA Approval For Batoclimab For Two Autoimmune Disorders Despite Positive Phase 3 Data
March 19, 2025
From Benzinga
Tech Stocks Surge, Steelmakers Jump On Trump's 25% Tariffs, Copper Hits 9-Month Highs: What's Driving Markets Monday?
February 10, 2025
From Benzinga
Earnings Scheduled For February 10, 2025
February 10, 2025
From Benzinga
'I'm One Of You' – How 'Anti-Woke' Warrior Vivek Ramaswamy Became A Billionaire At Only 38
November 18, 2024
From Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
From Benzinga
Price Over Earnings Overview: Roivant Sciences
October 18, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
From Benzinga
Organon, Howmet Aerospace And More: CNBC's 'Final Trades'
October 03, 2024
From Benzinga
From Benzinga
4 Analysts Assess Roivant Sciences: What You Need To Know
September 11, 2024
Tickers
ROIV
From Benzinga
Roivant Sciences Unveils New 'Vant' Subsidiary For In-Licensed Pulmonary Hypertension Drug From Bayer
September 10, 2024
From Benzinga
From Benzinga
Tickers
ROIV
From InvestorPlace
From Benzinga
From InvestorPlace
From InvestorPlace
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
From Benzinga
5 Value Stocks In The Healthcare Sector
February 19, 2024
From Benzinga
Earnings Scheduled For February 13, 2024
February 13, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
